BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36104997)

  • 1. The Relationship Between D-dimer and Prognosis in the Patients with Serum Alpha-Fetoprotein-Positive Gastric Cancer: A Retrospective Cohort Study.
    Zhang X; Wang W; Tian B; Wang Y; Jing J
    Clin Med Insights Oncol; 2022; 16():11795549221120158. PubMed ID: 36104997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinicopathological features and prognosis of serum AFP positive gastric cancer: a report of 16 cases.
    Liu D; Li B; Yan B; Liu L; Jia Y; Wang Y; Ma X; Yang F
    Int J Clin Exp Pathol; 2020; 13(9):2439-2446. PubMed ID: 33042357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer.
    Wang R; Li J; Xu D; Li R; Gong P
    Medicine (Baltimore); 2020 Nov; 99(47):e23326. PubMed ID: 33217870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of clinical characteristics and prognosis for patients with serum alpha-fetoprotein-positive gastric cancer.
    Zuo CT; Ju Q
    Minerva Med; 2015 Aug; 106(4):185-91. PubMed ID: 26418320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent metastatic patterns and prognosis after radical surgery in patients with alpha-fetoprotein-producing gastric cancer: a retrospective cohort study.
    Zhang F; Zhang X; Zhang X; Wang Y; Li T; Guo H; Ding P; Tian Y; Yang P; Li X; Meng N; Guo Z; Zhao Q; Zhang R
    Am J Cancer Res; 2024; 14(5):2124-2140. PubMed ID: 38859826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatoid Adenocarcinoma of Stomach: Emphasis on the Clinical Relationship with Alpha-Fetoprotein-Positive Gastric Cancer.
    Chen EB; Wei YC; Liu HN; Tang C; Liu ML; Peng K; Liu T
    Biomed Res Int; 2019; 2019():6710428. PubMed ID: 31915699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of claudin-18.2 in alpha-fetoprotein-producing gastric cancer compared to conventional gastric cancer.
    Weng W; Zhang M; Ni S; Tan C; Xu M; Wang X; Sun H; Wang L; Huang D; Sheng W
    J Gastrointest Oncol; 2022 Jun; 13(3):1035-1045. PubMed ID: 35837176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-evaluation of the prognosis of alpha-fetoprotein-producing gastric cancer from a single center: a case series study.
    Akabane M; Yago A; Haruta S; Ohkura Y; Ueno M; Udagawa H
    Langenbecks Arch Surg; 2023 Jan; 408(1):66. PubMed ID: 36695913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic and prognostic characteristics of alpha-fetoprotein-producing gastric cancer.
    He R; Yang Q; Dong X; Wang Y; Zhang W; Shen L; Zhang Z
    Oncotarget; 2017 Apr; 8(14):23817-23830. PubMed ID: 28423604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer.
    Kamiimabeppu D; Wakatsuki T; Takahari D; Fukuda N; Shimozaki K; Osumi H; Nakayama I; Ogura M; Ooki A; Shinozaki E; Chin K; Yamaguchi K
    Int J Clin Oncol; 2023 Jan; 28(1):121-129. PubMed ID: 36409433
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Maruyama S; Furuya S; Shiraishi K; Shimizu H; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Sudo M; Inoue S; Kono H; Ichikawa D
    World J Gastrointest Oncol; 2018 Oct; 10(10):344-350. PubMed ID: 30364858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma.
    Gong W; Su Y; Liu A; Liu J; Sun D; Jiang T; Xiang J; Chi C; Sun P
    Neoplasma; 2018 Mar; 65(3):326-330. PubMed ID: 29788728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study.
    Li L; Yang X; Ji W; Zhu Q; Yang X; Niu J; Li W
    BMC Gastroenterol; 2023 May; 23(1):142. PubMed ID: 37161409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma.
    Liu C; Xiao GQ; Yan LN; Li B; Jiang L; Wen TF; Wang WT; Xu MQ; Yang JY
    World J Gastroenterol; 2013 Mar; 19(11):1811-9. PubMed ID: 23555170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathologic features and prognosis of 51 patients with α-fetoprotein-producing gastric cancer].
    Liu X; Yang M; Gao J; Zhang S; Xi Y
    Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):231-4. PubMed ID: 25975796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High level of serum AFP is an independent negative prognostic factor in gastric cancer.
    Chen Y; Qu H; Jian M; Sun G; He Q
    Int J Biol Markers; 2015 Nov; 30(4):e387-93. PubMed ID: 26349668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 50-Year-Old Man with Fulminant Alpha-Fetoprotein-Producing Gastric Carcinoma and Disseminated Intravascular Coagulation.
    Longo R; Carassou P; Leguay C; Basin S; Thiebaut V; Paraschiv EA; Enea AM
    Am J Case Rep; 2021 Mar; 22():e928369. PubMed ID: 33667215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-fetoprotein is a significant prognostic factor for gastric cancer: Results from a propensity score matching analysis after curative resection.
    Reim D; Choi YS; Yoon HM; Park B; Eom BW; Kook MC; Ryu KW; Choi IJ; Joo J; Kim YW
    Eur J Surg Oncol; 2017 Aug; 43(8):1542-1549. PubMed ID: 28511775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report.
    Arakawa Y; Tamura M; Aiba K; Morikawa K; Aizawa D; Ikegami M; Yuda M; Nishikawa K
    Oncol Lett; 2017 Sep; 14(3):3039-3042. PubMed ID: 28928842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Serum Alpha-Fetoprotein Is a Significant Prognostic Factor for Patients with Gastric Cancer: Results Based on a Large-Scale Retrospective Study.
    Zhan Z; Chen B; Yu J; Zheng J; Zeng Y; Sun M; Peng L; Guo Z; Wang X
    Front Oncol; 2022; 12():901061. PubMed ID: 35847953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.